Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Jacques Appy
Introduction
Jacques Appy is a notable inventor based in Schlierbach, France. He has made significant contributions to the field of medical technology, particularly with his innovative designs aimed at improving patient care. His work focuses on creating devices that enhance the delivery of medication, ensuring safety and efficiency.
Latest Patents
Jacques Appy holds a patent for an automatic drug delivery device. This device is designed for dispensing a fluid medicament and includes several key components. It features a longitudinal housing, a removable cap, a syringe assembly with a hollow syringe body and an injection needle, and a drive mechanism. The drive mechanism is operatively coupled with a safety shield that is movable within the housing. This safety shield is biased into a proximal position to cover the needle tip, ensuring user safety. The device also includes a feedback mechanism that provides visual feedback to the user, indicating the actual state of operation through a visual indicator in a transparent window on the distal end of the housing.
Career Highlights
Jacques Appy is currently employed at Novartis AG, a leading global healthcare company. His role involves the development of innovative medical devices that aim to improve patient outcomes. His expertise in engineering and design has allowed him to create solutions that address critical needs in drug delivery systems.
Collaborations
Jacques has collaborated with several professionals in his field, including Andrew Bryant and Neil Cammish. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Jacques Appy is a distinguished inventor whose work in automatic drug delivery devices exemplifies the intersection of technology and healthcare. His contributions continue to impact the medical field positively, enhancing the safety and effectiveness of medication delivery systems.